Ono Aims to Decrease Sales Ratio of Long-Listed Drugs to 50% Level within FY2012: President Sagara

Gyo Sagara, President, Representative Director and CEO, Pharmaceutical In its business briefing held on May 9, Gyo Sagara, president, representative director and CEO of Ono Pharmaceutical, revealed the company’s three mid-term goals/tasks, in which the company intends to decrease the...read more